MCUJF - Medicure Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
6.45
0.00 (0.00%)
At close: 3:54PM EDT
Stock chart is not supported by your current browser
Previous Close6.45
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume1,846
Market Cap99.95M
Beta0.34
PE Ratio (TTM)5.99
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Medicure Inc. (MCUJF) a Great Stock for Value Investors?
    Zackslast month

    Is Medicure Inc. (MCUJF) a Great Stock for Value Investors?

    Is Medicure Inc. (MCUJF) a great pick from the value investor's perspective right now? Read on to know more.

  • Medicure, Inc. :MCUJF-US: Earnings Analysis: Q2, 2017 By the Numbers : August 11, 2017
    Capital Cube2 months ago

    Medicure, Inc. :MCUJF-US: Earnings Analysis: Q2, 2017 By the Numbers : August 11, 2017

    Categories: Yahoo FinanceGet free summary analysis Medicure, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Medicure, Inc. – Merck & Co., Inc., Cardiome Pharma Corp. and Eli Lilly and Company (MRK-US, CRME-US and LLY-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • Medicure, Inc. :MCUJF-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
    Capital Cube4 months ago

    Medicure, Inc. :MCUJF-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Medicure, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Medicure, Inc. – Medicines Company, Merck & Co., Inc., Cardiome Pharma Corp. and Eli Lilly and Company (MDCO-US, MRK-US, CRME-US and LLY-US) that have also reported for this period. ... Read more (Read more...)

  • Medicure, Inc.: Leads amongst peers with strong fundamentals
    Capital Cube11 months ago

    Medicure, Inc.: Leads amongst peers with strong fundamentals

    Categories: Yahoo Finance Medicure, Inc. relative valuation is OVERVALUED and it has a fundamental analysis score of 91. Our analysis is based on comparing Medicure, Inc. with the following peers – Medicines Company, Resverlogix Corp., Merck & Co., Inc., Cardiome Pharma Corp., Eli Lilly and Company and Eiger BioPharmaceuticals, Inc. (MDCO-US, RVX-CA, MRK-US, CRME-US, LLY-US and EIGR-US). Medicure, ... Read more (Read more...)